Chordia Therapeutics Inc. (TYO:190A)

Japan · Delayed Price · Currency is JPY

130.00

+6.00 (4.84%)

Mar 10, 2026, 2:13 PM JST

Revenue by Segment

Financials in millions JPY. Fiscal year is September - August.

Millions JPY. Fiscal year is Sep - Aug.

Fiscal Year	FY 2023
Period Ending	Aug '23 Aug 31, 2023
Drug Development Business	2.50B
Total	2.50B

Source: S&P Global Market Intelligence.